YS

Younis Saleem Bhat

Active Director Director DIN 10134896
DIN 10134896 First appointment Apr 2023 Primary industry Paper
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Younis Saleem Bhat

Data last updated:

Younis Saleem Bhat is a Director at Cadion Pharmaceuticals Private Limited (since 2023). The company operates in Paper.

DIN 10134896
Primary Designation Director
Industry Paper
First Appointment 26 Apr 2023
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director26 Apr 20232023Active

Board colleagues of Younis Saleem Bhat

NameDINCompanyDesignation
Sajawal Mehraj10134895Cadion Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Cadion Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Younis Saleem Bhat

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Younis Saleem Bhat

Younis Saleem Bhat currently holds 1 directorship: Cadion Pharmaceuticals Private Limited (Director, since 26 Apr 2023).

Younis Saleem Bhat was first appointed on 26 Apr 2023 as Director at Cadion Pharmaceuticals Private Limited.

The current boards of Younis Saleem Bhat's companies include Sajawal Mehraj (Cadion Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available